iiCON: A booster shot for the medical and pharmaceutical sector in North-west England

Published on

At the Open Innovation Hub, we are proud to be partnered with the iiCON Infection Innovation Consortium.

The iiCON Infection Innovation Consortium is creating specialist, commercially sustainable research platforms for infectious disease therapeutics in north-west England.

The need for infectious disease control remains high in the UK and internationally, with Covid-19, anti-microbial resistance, hospital-acquired infections, Zika, Ebola, TB, malaria and HIV still prevalent.

Based across the Liverpool City Region, Cheshire and Warrington, this project will transform product discovery and development, helping products go from lab to patients faster, cheaper and in more effective formats.

It is led by Liverpool School of Tropical Medicine and builds on research and innovation excellence in North-West England. iiCON will generate hundreds of jobs in the area, and attract substantive international investment to boost the local economy.

More on the project: https://www.ukri.org/our-work/our-main-funds/strength-in-places-fund/wave-2-seedcorn-funded-proposals/